Lincoln Pharmaceuticals Q1 FY23 consolidated profit up at Rs. 15.01 Cr
News

Lincoln Pharmaceuticals Q1 FY23 consolidated profit up at Rs. 15.01 Cr

The company has reported total income of Rs. 129.96 crores during the period ended June 30, 2022.

  • By IPP Bureau | August 11, 2022

Lincoln Pharmaceuticals Limited has posted net profit of Rs. 15.01 crores for the period ended June 30, 2022 as against net profit of Rs. 11.02 crores for the period ended March 31, 2022. The company posted net profit of Rs.17.70 crores for the period ended June 30, 2021.

The company has reported total income of Rs. 129.96 crores during the period ended June 30, 2022 as compared to Rs. 104.47 crores during the period ended March 31, 2022. It reported total income of Rs.124.1995 crores during the period ended June 30, 2021.

Upcoming E-conference

Other Related stories

Startup

Digitization